Sichuan Saizhuo Pharmacy Co., Ltd.

Primary objective: To investigate the bioequivalence of the two preparations in healthy subjects, using pitavastatin calcium tablets (specification: 2 mg) of Sichuan Saizhuo Pharmaceutical Co., Ltd. as the test preparation and pitavastatin calcium tablets (trade name: LIVALO KOWA ®, specification: 2 mg) of Kowa Company, Ltd. as the reference preparation according to the relevant provisions of bioequivalence tests. Secondary objective: To observe the safety of the test preparation and the reference preparation in healthy subjects.

Primary objective: To compare the absorption rate and extent of cefixime dispersible tablets provided by Sichuan Saizhuo Pharmaceutical Co., Ltd. with cefixime granules (Cefspan) produced by Changshengtang Pharmaceutical Co., Ltd. in healthy human subjects according to the relevant provisions of bioequivalence test, and to investigate the bioequivalence of the two preparations in human subjects. Secondary objective: To observe the safety of the test preparation cefixime dispersible tablets and the reference preparation cefixime granules in healthy subjects.

Using Cefdinir Capsules (0.1 g) produced by Sichuan Saizhuo Pharmaceutical Co., Ltd. as the test preparation and Cefdinir Capsules (0.1 g, trade name: Quanzefu) produced by Astellas Pharma Inc. as the reference preparation, fasting and fed bioavailability and bioequivalence studies were conducted in healthy humans. The relative bioavailability of the test preparation was calculated, and the fasting and fed bioequivalence of the two preparations was evaluated.